Christine Regan Lindenboom | Alnylam Pharmaceuticals, Inc. |
John M. Maraganore | Alnylam Pharmaceuticals, Inc. |
Akshay K. Vaishnaw | Alnylam Pharmaceuticals, Inc. |
Barry E. Greene | Alnylam Pharmaceuticals, Inc. |
Manmeet S. Soni | Alnylam Pharmaceuticals, Inc. |
Yvonne L. Greenstreet | Alnylam Pharmaceuticals, Inc. |
Alan Carr | Needham & Co. LLC |
Benjamin Burnett | Stifel Financial Corp. |
Anupam Rama | JPMorgan Securities LLC |
Ted A. Tenthoff | Piper Jaffray & Co. |
Gena Wang | Barclays Capital, Inc. |
Terence Flynn | Goldman Sachs & Co. LLC |
Madhu Kumar | B. Riley FBR, Inc. |
Keith Tapper | BMO Capital Markets |
Ladies and gentlemen, thank you for standing by. Welcome to the Alnylam Pharmaceuticals Conference Call Third Quarter Earnings. There will be a question-and-answer session to follow. Please be advised that this call is being taped at the company's request. I would now like to turn the call over to the company.